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Antimicrobial Drug 
Use and Antibiotic-
Resistant Bacteria
To the Editor: The article by Har-
ris et al., published in the August 2007 
issue of Emerging Infectious Diseases, 
examined the risk factors for selecting 
extended-spectrum  β-lactamase–pro-
ducing  Enterobacteriaceae in inten-
sive-care patients and found that ex-
posure to piperacillin/tazobactam and 
vancomycin were independent risk 
factors (1). Although antimicrobial 
drug use has been historically linked 
to antibiotic resistance in bacteria, we 
should not miss the perspective that 
such a risk factor mostly favors the 
cross-transmission of preexisting an-
tibiotic-resistant bacteria, taking into 
account the disruption of the endog-
enous microﬂ  ora, rather than the se-
lection of “de novo” resistant mutants 
(2). This supposition is supported by 
many articles that have found genetic 
similarity between antibiotic-resistant 
microorganisms that occur in hospi-
talized patients, as well as by the fact 
that most of these pathogens exhibit 
cross-resistance with different classes 
of drugs, which should be extremely 
rare on a mutation basis. 
This hypothesis is also supported 
by the evidence that healthcare work-
ers frequently do not obey simple 
infection control precautions such 
as practicing hand hygiene between 
contact with different patients (3–6). 
That is likely why Larson et al., in a 
multicenter study in the United States, 
recently found no relationship be-
tween antimicrobial drug control poli-
cies and level of antibiotic resistance 
in bacteria, but did ﬁ  nd an association 
between lower levels of antibiotic re-
sistance in Staphylococcus aureus and 
enterococci and high compliance with 
hand hygiene (7).
Therefore, perhaps we should start 
looking for risk factors for being colo-
nized or infected by any antimicrobial 
drug–resistant bacterium, including 
in our analysis some infection control 
measures adopted commonly during 
outbreak investigations, such as expo-
sure to doctor A or nurse B, proximity 
to a known colonized patient, under-
stafﬁ  ng during the period of the study, 
and so forth. If we do so, we will likely 
ﬁ  nd that antimicrobial drug use is not 
a completely independent risk factor 
for the mentioned outcome, but a risk 
factor closely related to the availabil-
ity of the antibiotic-resistant microor-
ganism in the local environment or on 
our own hands.
Fernando Bellissimo-
Rodrigues*
*Hospital das Clínicas da Faculdade de Me-
dicina de Ribeirão Preto, São Paulo, Brazil
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In Response: We appreciate 
the comments by Dr. Bellissimo-Ro-
drigues regarding our article analyzing 
risk factors for surveillance-culture 
positivity with extended-spectrum β-
lactamase (ESBL)–producing bacte-
ria (1). We agree with the author that 
patient-to-patient transmission is a 
potentially important causal factor in 
the emergence of resistance for ESBL-
producing bacteria as well as for other 
antimicrobial drug–resistant bacteria, 
such as vancomycin-resistant entero-
cocci, methicillin-resistant Staphy-
lococcus aureus, and drug-resistant 
Pseudomonas and Acinetobacter spp. 
For each of these resistant organ-
isms, a complicated interplay likely 
exists between the causal importance 
of antibiotic selective pressure and 
patient-to-patient transmission by 
healthcare workers (2–4). The relative 
importance of these 2 causal mecha-
nisms needs to be determined for 
each individual antimicrobial-resistant 
bacterium. The relative causal impor-
tance may be different for different 
outcomes: colonization on admission, 
colonization acquisition, and progres-
sion from colonization to infection. 
Understanding the relative importance 
for each of these outcomes is needed 
before determining whether infection 
control interventions or antimicrobial 
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fective. For example, we have pub-
lished work that demonstrates that 
patient-to-patient transmission is im-
portant for colonization acquisition of 
ESBL-producing Klebsiella spp. and 
Escherichia coli (5).
We believe that a couple of points 
require clariﬁ  cation. In our article, we 
looked at risk factors for colonization 
with ESBL-producing bacteria on ad-
mission to an intensive care unit. We 
did not examine risk factors for select-
ing ESBL-producing bacteria as the 
letter implies. For the antimicrobial 
drugs identiﬁ  ed as potential risk fac-
tors, we clearly stated in the discus-
sion that the risk factors identiﬁ  ed 
may be causally related to the out-
come of ESBL-colonization or may 
only be statistically associated. We 
argue that even risk factors identiﬁ  ed 
are not causal; they may be impor-
tant because they can help determine 
which patients may need empiric an-
timicrobial drug therapy targeted to 
the ESBL-producing bacteria. Future 
research work is still needed to assess 
the relative importance of patient-to-
patient transmission versus antimicro-
bial selective pressure.
Anthony D. Harris,* 
Kerri Thom,* 
and Jessina McGregor†
*University of Maryland, Baltimore, Mary-
land, USA; and †Oregon State University, 
Portland, Oregon, USA
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ANOTHER DIMENSION
Aftermath
George Held
It’s not the storm itself—wind and rain lashing shore,
uprooting trees, toppling poles and dousing lights,
ﬂ  ooding cellars and roads, capsizing boats—
but the aftermath—the bright calm, the pair
of drowned cats crumpled against the picket fence,
the parlor of Izzy’s shack open for inspection,
the walls fallen ﬂ  at on all sides, your own 
roof ﬁ  lling the front yard, covering your car,
and your own twin daughters dazed by Nature’s 
petulance—that makes you reconsider
your life and weigh your possessions and the cost
of putting down stakes too near the coast
as the globe warms, and storms grow worse.
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